Current Capabilities

Capture multiple plasma proteins using PlasmaCap EBA

Utilizing the flexibility of the PlasmaCap EBATM technology, our scientists have generated and tested protocols for capturing plasma proteins from materials commonly available including:

  • Fresh frozen plasma
  • Cryo-poor plasma
  • Cohn supernatants
  • Cohn fractions


From these materials, this technology is able to capture many proteins including:

  • Immunoglobulin G (IgG)
  • Human Serum Albumin (HSA)
  • Alpha-1 Antitrypsin (AAT or A1AT)
  • Factor VIII (FVIII)
  • von Willebrand Factor (vWF)
  • Fibrinogen
  • Prothrombin Complex Concentrate (PCC)
  • Antithrombin III (AT or ATIII)
  • Transferrin (Tfn)


To learn more about how plasma protein manufacturers and other biomanufacturing organizations can take advantage of PlasmaCap EBA, please contact us.

plasma-cap therapurebio-plasmacap

Disclaimer | Privacy Policy | Accessibility | Sitemap

PlasmaCap EBA is a trademark of Therapure Biopharma Inc.

Copyright ©2013 Therapure Biopharma Inc.

plasma-cap